Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

MLA

Gore, Steven D., et al. “Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms.” Cancer Research, vol. 66, no. 12, June 2006, pp. 6361–69. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-06-0080.

APA

Gore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E., Rudek, M. A., Zhao, M., Smith, B. D., Manning, J., Jiemjit, A., Dover, G., Mays, A., Zwiebel, J., Murgo, A., … Herman, J. G. (2006). Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Research, 66(12), 6361–6369. https://doi.org/10.1158/0008-5472.CAN-06-0080

Chicago

Gore, Steven D, Stephen Baylin, Elizabeth Sugar, Hetty Carraway, Carole B Miller, Michael Carducci, Michael Grever, et al. 2006. “Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms.” Cancer Research 66 (12): 6361–69. doi:10.1158/0008-5472.CAN-06-0080.